Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Crohn's & Colitis Australia is the national Australian not-for-profit organization focused on people living with inflammatory bowel disease, particularly Crohn's disease and ulcerative colitis. Legally it operates as the Australian Crohn's and Colitis Association and trades as Crohn's & Colitis Australia. The organization provides patient support services, nurse and helpline access, education, advocacy, awareness campaigns, membership programs, and research grants rather than developing proprietary therapeutics. It also works with healthcare professionals, governments, and the broader community on standards of care, policy initiatives, and disease-burden research. CCA's activities are centered on improving quality of life, strengthening IBD care in Australia, and advancing toward better treatments and ultimately a cure.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Crohn's & Colitis Australia.